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Background: Tensions between IRBs and researchers in the US and elsewhere have increased, and may affect
whether, how, and to what degree researchers comply with ethical guidelines. Yet whether, how, when, and why
IRBs respond to these conflicts have received little systematic attention.
Findings: I contacted 60 US IRBs (every fourth one in the list of the top 240 institutions by NIH funding), and
interviewed leaders from 34 (response rate = 55%) and an additional 12 members and administrators. IRBs often try
to respond to tensions with researchers and improve relationships in several ways, but range widely in how, when,
and to what degree (e.g., in formal and informal structure, content, and tone of interactions). IRBs varied from open
and accessible to more distant and anonymous, and in the amount and type of “PR work” and outreach they do.
Many boards seek to improve the quantity, quality, and helpfulness of communication with PIs, but differ in how.
IRBs range in meetings from open to closed, and may have clinics and newsletters. Memos can vary in helpfulness
and tone (e.g., using “charm”). IRBs range considerably, too, in the degrees to which they seek to educate PIs,
showing them the underlying ethical principles. But these efforts take time and resources, and IRBs thus vary in
degrees of responses to PI complaints.
Conclusions: This study, the first to explore the mechanisms through which IRBs respond to tensions and
interactions with PIs, suggests that these committees seek to respond to conflicts with PIs in varying ways – both
formal and informal, involving both the form and content of communications. This study has important
implications for future practice, research, and policy, suggesting needs for increased attention to not only what IRBs
communicate to PIs, but how (i.e., the tone and the nature of interactions). IRBs can potentially improve
relationships with PIs in several ways: using more “open doors” rather than anonymity, engaging in outreach (e.g.,
through clinics), enhancing the tone as well as content of interactions, educating PIs about the underlying ethics,
and helping PIs as much and proactively as possible. Increased awareness of these issues can help IRBs and
researchers in the US and elsewhere.
Keywords: IRBs, Research ethics, Responsible conduct of research, Ethics education, Professionalism, Medical
education, Organizational ethics, Compliance, CommunicationBackground
Conflicts between institutional review boards (IRBs) –
or research ethics committees (RECs), as they are called
in many countries – and researchers have mounted over
recent decades, yet little systematic attention has been
given to critical questions of whether IRBs acknowledge
and respond to these tensions, and if so, how, when, and
why. In the US and elsewhere, IRBs have been increas-
ingly faulted for several reasons, including extension ofCorrespondence: rlk2@columbia.edu
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reproduction in any medium, provided the ortheir review into the social sciences [1], and discrepan-
cies in reviews of the same protocol in multi-site studies,
delaying research, and impeding comparison of data [2].
Critics contend that IRBs have become overly bureau-
cratic, focused on the ethics of documentation [3], and
may be “dyfunctional” [4]. These problems frustrate
researchers, generating tensions. In other countries as
well, IRBs have been criticized – e.g., as inefficient [5].
As a result, for two decades, debates have arisen over
whether the status quo should be altered, and if so, how.
Critics have call for increased centralization [6,7],
though in the US, this alternative has been instituted. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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agement and Budget released an Advance Notice of Pro-
posed Rule Making (ANPRM) recommending changes to
45-CFR-46 (the so-called “Common Rule”), the federal
regulations governing IRBs [8,9]. The ANPRM addresses
several issues, reflecting in part researchers’ complaints
about IRBs. Specifically, the document seeks to increase
central review; reduce variations between IRBs that can
impede research; allow some minimal risk research to be
“excused” from IRB review; and address challenges raised
by biobanking. But whether any of these possible changes
in formal structural elements of IRB reviews will be
made, and if so, which, to what degree, in what form, and
when, is unclear. Critical questions arise, too, of whether
other changes may be needed or beneficial as well in im-
proving the current system.
Importantly, though PIs’ complaints about IRBs have
been described [1,2,6,10,11], little, if any, attention has
been given to whether IRBs respond to these critiques,
and if so, how. Yet researchers’ beliefs that IRBs are un-
fair may dissuade these researchers from fully adhering
to research ethics guidelines [12]. Logistical aspects of
IRBs have been examined (e.g., sociodemographics of
members, and time required for IRB approval [2,13]),
but whether IRBs decide to address strains with
researchers, and if so, how, and to what degree, have not
been systematically examined.
As part of a qualitative, in-depth interview study of IRB
chairs, focused on understanding their views, attitudes,
and roles regarding research integrity (RI), broadly defined
[14], many issues arose – e.g., concerning differences in
how IRBs made decisions and interacted with PIs, and
viewed and approached conflicts of interest [15], central
IRBs [16], research in the developing world [17], and var-
iations between IRBs [18]. Yet, other separate issues arose
concerning how IRBs addressed interactions and conflicts
with PIs, and tried to improve these relationships. Since
qualitative research allows for further probing of themes
that arise, these interviews then explored these mechan-
isms in greater detail. Crucial questions emerged of how
IRBs responded to PIs, and what approaches facilitated
and/or impeded their relationships. This paper thus ana-
lyzes and explores these realms.
Methods
As described elsewhere [14], in-depth telephone inter-
views of approximately 1 to 2 h each were conducted
with 46 chairs, directors, administrators, and members.
The leadership of 60 IRBs (every fourth one in the list of
the top 240 institutions by NIH funding) was contacted
and IRB leaders from 34 of these institutions were inter-
viewed, yielding a response rate of 55%. In certain cases,
both a chair/director as well as an administrator from an
institution were included (e.g., if the former thought thatthe latter could better provide detail about certain areas).
Thus, in all, 39 chairs/directors and administrators from
these 34 institutions were interviewed. To understand
the impact of varying social and institutional milieus in
these domains, institutions ranged in location, size, and
public/private status. Every other interviewee was also
asked to disseminate information about the study to
their IRB members, in order to also recruit 1 member
from each IRB. Seven other members were thus
included, as well.
As summarized in Table 1, the 46 interviewees included
28 chairs/co-chairs; 10 administrators (including 1 dir-
ector of a compliance office); and 7 members. In all, 58.7%
were male, and 93.5% were White. Interviewees were dis-
tributed across geographic regions, and institutions by
ranking in NIH funding. This study was approved by the
Columbia University Institutional Review Board. All inter-
viewees gave informed consent.
Appendix A presents relevant portions of the semi-
structured interview guide, which sought to elucidate
interviewees’ aspects of their decisions, lives, and social
situations by trying to grasp their own experiences and
language, not by imposing theoretical structures [19].
The methods draw on elements from grounded theory
[20].
After completion of all of the interviews, a trained re-
search assistant (RA) and the principal investigator (PI)
conducted additional analyses in two phases. In the first
phase, each interview was read, and “core” codes or cat-
egories were assigned to blocks of text (e.g., instances of
IRB interactions and tensions with PIs). Together, these
independently-developed coding schemes were then
reconciled. A coding manual was produced, listing and
defining the codes. Any areas of disagreement were
explored until consensus was reached. Issues that did
not fit in the original coding manual were discussed, and
modifications were made when necessary.
In the second phase of the study, the two coders inde-
pendently content-analyzed the interviews, examining
the main subcategories, and ranges of variation in each
of the core categories. They reconciled sub-themes into
a single set of “secondary” themes and an elaborated set
of core categories. Sub-themes included, for example,
specific types of interactions with researchers (e.g., use
of memos, face-to-face meetings), PI reactions (e.g., PIs’
complaints about the IRB to institutional leadership),
and IRB efforts to reduce conflicts with PIs (e.g., chan-
ging the tone of memos sent).
Codes and sub-codes were then used in analysis of all of
the interviews, with the two coders analyzing all interviews.
Results
As summarized in Figure 1, and described more fully
below, IRBs face several choices regarding both the
Figure 1 Responses of IRBs to tensions with PIs.
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committees often try to respond to tensions with PIs,
and improve relationships in various ways, but range in
how, when, and to what degree. IRBs varied in the for-
mal and informal social structures, and the content and
tone of interactions with PIs, and confronted several
challenges.
From anonymity to open doors
In general, IRBs differed in the types, amounts, and ef-
fectiveness of their efforts, and ranged across a spectrum
from remaining distant and anonymous, to being open
and accessible. IRB members often said they knew they
were seen as “obstructionistic” by PIs, but these intervie-
wees varied in how much they were troubled by, and
responded to, these perceptions. Chairs generally said
that they were supportive of PIs, but they differed widely
in how, and to what degree they demonstrated that
stance. IRBs often adopted approaches to try to reduce
tensions, but these methods then had both strengths and
limitations that IRBs confronted.
Some IRB leaders suggested that they were highly at-
tentive to PI views, and that they tried to be “open” and
helpful, while others expressed these concerns much
less. For example, some IRBs tried to be very open in
both the form and tone of the interaction.
Our approach here is: “Please call.” Not: “We’re out to
get you.” With a lot of IRBs, the relationship and
rapport they have with the faculty causes the problem.
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picking up the phone and trying to get some
information. That’s just a general philosophy, tone,
and culture. IRB26
IRBs may thus differ in both their implicit and explicit
attitudes and practices.IRB anonymity
In contrast, other interviewees suggested that their com-
mittees remained more distant from PIs. Much of IRB
work occurs behind closed doors, and chairs may try to
shield IRB members from researchers’ criticism by keep-
ing these members anonymous. Such anonymity can re-
sult from several causes. For instance, a reviewer may
have a relatively low position in the institutional hier-
archy, and not want to offend superiors on whom his or
her future may depend.
One scientist was new to the IRB, and was appalled at
a colleagues’ poorly thought-out protocol, but
unwilling to go to him outside of the meeting, and
make suggestions. The PI probably wouldn’t have
listened, so we just kind of limped along with it.
IRB26
This anonymity can thus create tensions, protecting the
reviewer, but potentially delaying or hampering streamlin-
ing of a review. To avoid friction with PIs, many IRBs have
reviewers of specific protocols remain anonymous.
At our institution, the cancer researchers know who
the cancer reviewers are – from whom the feedback
comes. However, friction from that confrontation is
held to a minimum. We give members an option of
whether to reveal themselves or not when
communicating to PIs prior to committee meetings.
We respect reviewers’ desire for anonymity and
confidentiality. If members have questions for a PI,
they can go through IRB staff instead. Otherwise, our
IRB membership lists are provided to PIs along with
our correspondence, making the names of the
reviewers known. IRB9
Regarding openness to PIs, IRBs may develop their
own group processes and culture that can be difficult to
change. A chair may try to alter an IRB by adding mem-
bers who, he or she feels, will optimally perform their
tasks. The chair can also dismiss other members. The
interviewee above wants members to “reach out” to PIs,
and he has:
. . .removed any member from the IRB who wants to
remain permanently anonymous, because we requirethat board members make an effort to reach out to
our PIs. That’s just pure old marketing, and good will
with our researchers. That’s how we change the
perception here of the IRB. IRB9
Some IRBs may thus see themselves as having to ac-
tively “market” their services (i.e., to engender support
from researchers).
When he revamped the IRB, to improve relationships
with researchers, this director asked a dozen members
to leave.
When we reorganized, we removed 12 members, who
had been on the IRB for many years, because most of
them had no desire to communicate with
investigators prior to meetings. One of the
prerequisites to then becoming a member was
willingness to reach out and contact PIs prior to
committee meetings. At times, they kept
confidentiality when it was a personal colleague, or
friend, or someone they work with closely. That’s OK.
IRB9
IRB members can thus vary in their interest and will-
ingness to communicate with PIs – i.e., the degrees to
which they would “reach out.”
Questions arise of whether IRB decision-making pro-
cesses should be more transparent to not only a particu-
lar PI, but more broadly. IRBs keep minutes private,
along with all correspondence and decisions (except to
the PI involved). Yet at times, certain interviewees felt
that heightened transparency could potentially also im-
prove perceptions of IRBs among PIs.
Minutes are not now publicly available, but should be.
I don’t see why not. I guess researchers may feel it’s
embarrassing to have your stuff rejected. IRB22
Some interviewees felt that redaction of details at any
institution may also be hard, but it is not possible.Outreach and public relations (PR) work
IRBs varied in the amount and type of “PR work” and
outreach they do with PIs, with some boards working
hard to convey the message that “we’re not the enemy.”
As one chair said, “Our educational sessions have
helped. Because the IRB members are human beings.”
(IRB4) IRBs may thus try to shape their image and alter
the notion that they are a faceless bureaucracy, rather
than consisting of fellow individuals.
At times, interviewees felt that PIs blamed IRBs for
trying to make protocols conform to federal regulations.
An IRB may try to establish “good PR” to help reduce
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anonymous.
Our IRB has done years of public relations work all
over campus saying, “We’re not the enemy. We’re not
here to hurt you. We’re here to help you, to talk with
you. Tell us what problems you’re having. How can
we assist?” That hasn’t always been the case here.
IRB39
IRBs and institutions may also thus try to change their
approaches over time.
Some IRBs go further, asking PIs how the IRB can im-
prove its interactions and relationships. In these efforts,
IRBs can be very strategic – being proactive, and target-
ing wary researchers.
We have identified departments that are particularly
hard to work with, and said, “Can we come talk to
you?. . .Let us know how we can work with you.” We
go make presentations to faculty meetings, project
coordinators, or individual faculty members: “How
can we make this better for you?” IRB39
Certain IRBs, recognizing that they are viewed warily
by PIs, explicitly try hard to alter these negative percep-
tions, to give the message, “We’re not devils. We’re
doing a good job” (IRB27) – seeking to reverse this
metaphor of embodying evil (i.e., “devils”).
Chairs differ in these efforts, which can take time and
effort. New chairs may adopt methods that are new to
an institution. One started calling new PIs.
I had some tools that this campus hadn’t seen before.
I just picked up the phone and said, “Can I come and
show you what this is all about? Because I know
you’re not going to know.” And they were fine with it.
I tell them it’s going to make it a whole lot easier.
IRB21
He also invites PIs to educate the IRB, which he thinks
works well.
If we have new methodologies, protocols – where the
committee is frankly just ignorant – they start out
gray. We usually invite that investigator to come in –
if they have an illustration or tools to help us
understand. Then the committee can get educated.
From a PR standpoint, that’s helped, because
investigators feel we’re willing to be taught, and reach
out. IRB21
Open door policies
Many chairs seek to improve relationships with PIs
through the structure and amount of other kinds ofinteractions as well, striving to maintain “open door” pol-
icies, making themselves directly and highly accessible to
PIs via email, phone, or cell phone. These types of phys-
ical and logistical structures of personal interaction may
shape psychological and social attitudes and vice versa.
But the nature, extent, and rationales involved varied.
Here, too, chairs may play critical roles, and prod their
IRB to collaborate with PIs as much as possible. “We en-
courage the reviewers to work constructively with the
reviewees, not have one of those hands-off things.”
IRB33
Chairs may push for open doors because of their per-
sonal, political, and/or bureaucratic philosophy. Some
chairs were wary of bureaucracies. (“We are easy, and
try to be accessible.” IRB5) Another chair, who is a law-
yer, tries to avoid having to “police” researchers. “I really
hate having to deal with compliance issues. I hate being
the enforcer. . .That’s not fun. That’s not what I do this
for.” (IRB19)
Other factors, such as structural space parameters, can
also play important roles in shaping IRB-PI relationships.
As one IRB administrator said,
At times, it has more to do with physical office
design: we don’t have a receptionist. When we had
someone between us and the world, PIs said that I
“suddenly started screening calls,” or “didn’t have an
open door policy anymore.” Now, researchers feel
they can just come in and sit down, and we can talk
about their protocol – what they haven’t addressed,
whether they can address it, and whether I can
explain to the board why it’s not there – that it’s on
its way. IRB13
At many institutions, interviewees complained that
their IRBs invited PIs to meetings, but that these PIs
often did not attend. These interviewees felt that such
attendance could improve relationships – showing that
IRBs are trying to be reasonable. Chairs may be sur-
prised that researchers do not accept these invitations.
It’s an open forum meeting. We tell all researchers to
come. But they won’t. It’s a two or three-hour evening
meeting, though they don’t have to come to the whole
thing. It would help if they could look around the
table and see their colleagues, and people from the lay
community, and clergymen: this isn’t a group of cynics
and big red pens. We really discuss the issues.
Researchers just need to realize that this is what
actually happens during the meetings, and we’re all
pretty reasonable. IRB27
Some chairs thus try to have PIs not see IRBs simply
as faceless bureaucrats.
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sensitive to researchers.
It’s tempting, and easier, to sit around a table and be
really tough and critical and blunt when we have
some anonymous individual – we’ve got a name
there, but nobody knows them. When you have met
the individual, you tend to temper those kinds of
remarks. Even if ultimately the message is
the same, we’ve backed off on the brute force.
IRB21
It may be harder for IRBs to be overly harsh and cal-
lous to a PI when meeting him or her in person, as
opposed to interacting only through memos.
Yet other IRBs may prefer to close their meetings, or
struggle to determine what to do. One administrator said,
“In the past, the IRB would have investigators go to the
meeting. Now they’ve closed them, which is helpful.”
(IRB23)
Several IRBs established other institutional structures
as well, such as “clinics,” to address PI concerns outside
of formal reviews, per se.
We started doing clinics. Researchers can meet with a
subset of the IRB, and talk about what they want to
do, and how to write their protocol. That helped. It
was in a sense a pre-review, but also worked through
questions that stymied the investigator from putting
the protocol in. Mostly, [researchers] were afraid it
wouldn’t get through. Everybody really appreciated it
– both the IRB members (because they got better
protocols), and the investigators (because they better
understood the processes, and could then write better
protocols). IRB28
Such meetings and workshops may enhance openness,
transparency, and communication.
The clinics showed the investigators what we’re
thinking, and brought them into the process, rather
than just dropping the protocol off in some box, with
a closed door. IRB28
To improve relationships, other IRBs established on-
line or in-print newsletters with updates – e.g., a “tip of
the week.” As one chair said,
We did a newsletter to keep people up-to-date,
because they are not in the IRB world, and don’t
know something has changed until it gets sprung on
them. They said, “We’d like to know ahead of time
what’s going on.” So, we established “The Tip of the
Week.” It was easy to email: write it once, click a
button, and send. IRB4IRBs can also disseminate such “tips” in response to
errors that PIs may make. Thus, such advice can also
potentially help prevent problems. This chair continued,
A couple of investigators changed a study, and the
IRB didn’t become aware until the protocol came up
for renewal. So, we sent out a “Tip of the Week” that
said you can’t do that! “But if a subject is on site, and
a procedure needs to be repeated, and the PI’s best
medical judgment is that it needs to be repeated, then
repeat it. Don’t wait for IRB approval.” We tried to
put federal regulations into a real world environment.
IRB4
Such advice may thus be helpful in several ways.
Yet these efforts can consume much of a chair’s or
administrator’s time. A chair who spends a lot of time
with PIs to diminish the IRB’s reputation of being
obstructionistic may find that these activities take more
time than he or she is compensated for. The chair above
said his time is billed at 20%, but is really 35–40%.
I spend more time with investigators than do any of
our members, because I am so sick and tired of
hearing that the IRB is a roadblock or a stumbling
block. I don’t like the committee having that
reputation. So I work very hard with our investigators
to make that not the case. IRB4
The time demands of such enhanced IRB availability
can necessitate difficult tradeoffs, and cause tensions.
IRB chairs and administrators can become overwhelmed,
and need to weigh the advantages of open doors vs. lim-
ited resources.
Hence, while some chairs are highly concerned about PI
complaints and try hard to reduce these, other chairs may
be far less responsive or flexible. The latter may remain
more removed from PIs, and interact with them more in-
directly. IRBs may also struggle to achieve a balance.
Boards may try to adopt an overall “open” policy, but ad-
just and limit their approach with difficult PIs over time.
Some people are chronically unhappy – complainers.
No matter what we do, they’re unhappy. So, we try to
be diplomatic, gracious, and non-confrontational, but
hold our ground. We’re not going to cave in just
because somebody is yelling at us. We can’t turn the
world on its head because a PI got his protocol in
late! IRB40Changing the tone and content of interactions
Helpful memos: the content of communications
IRBs often sought to improve, too, the quantity, quality,
and helpfulness of written communication with individual
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Both the content and the tone of communication and
interactions can be important. Some chairs write lengthy
memos to PIs in response to submitted protocols, assist-
ing these PIs in rewriting studies. Yet these activities can
take time, and chairs and staff may therefore carefully
choose to which PIs and studies to devote such efforts. As
one administrator said, “Some people just want you to
write the darn thing for them. That’s not my job.” (IRB23)
Hence, if a PI has a track history of poorly written pro-
posals, the IRB may invest less such effort.
For a very flawed study, I am much more likely to
write back a three-page letter with 20 points, basically
re-writing the protocol for them, than I am to
disapprove it. I disapproved one from an investigator
with a track record of submitting flawed protocols,
and sloppy work – making us do a tremendous
amount of work. Instead of doing the work for him
for the fifth time, I said, “No. Here are the major
problems. Fix it.” Instead of a three-page letter, I write
a half-page letter, identifying the major issues, and put
the ball back into their court. IRB40
However, for various reasons, PIs may not all respond to
these efforts as IRBs expect or hope. Interviewees felt that
PIs revise and resubmit most, but not all, protocols. After
receiving the three-page memo mentioned above, this chair
said that the PI never resubmitted the proposal.
I wrote an extensive, helpful letter, and he never
responded. My guess is that he couldn’t fix it, and was
overwhelmed. He is not a good researcher. But, for
99% of researchers, the concerns are fixable. They fix
them, respond, and move on. IRB40
Charm: establishing the right tone in communications
IRBs also attempt to mitigate friction with individual PIs
through not only the content of communications, but
the tone as well. Several chairs tried hard to use a re-
spectful tenor that gave the message that the IRB wishes
to be helpful, not obstructionistic; but such an approach
was not always easy to establish and maintain.
Several interviewees described the importance of hav-
ing what one chair calls a “deft touch.”
I always fear that faculty feel worn down by
regulations, and don’t have enough time for anything.
I just try to get them to keep true to the IRB’s
mission, and not just dismiss it as a whole set of
hoops they have to jump through. Sometimes that just
requires a deft touch. I don’t know if I’m even good at
it – I hope I am. But that’s what I try to do. I’d much
rather somebody get a phone call from me, since I’malso a doctor, and have done research, than just hear
from somebody in the office that they didn’t do
something. IRB32
Chairs may thus also be uncertain as to how effective
they are in these efforts. Achieving this tone, while sim-
ultaneously ensuring that PIs are following the regula-
tions, can also be among the most difficult aspects of
IRB work – doing PR while trying to protect subjects as
much as possible.
The hardest part of being an IRB administrator is
walking this fine line. We are facilitators as well as
monitors, and maintain a positive PR – we’re here to
facilitate and help you with the process. At the same
time, we’re here to make sure you comply with the
regulations. Keeping the line of communication and
trust open is critical, and setting the tone. IRB16
IRB chairs may thus struggle to have their staff use
“the right manner” to improve relationships with PIs,
but establishing and maintaining such a tone may in part
be an innate ability that not everyone equally shares.
It’s a challenge not only to find folks who have the
talent for IRB work, but to teach people to get the
right tone and balance, not shaking a stick at
researchers, but trying to be collegial, and knowing
when and how to make exceptions, be flexible, or
compromise. We don’t want to be one of those IRB
offices that people hate, and complain about all the
time. IRB18
To strengthen relationships with PIs, and defuse fric-
tion, one chair tries to “say no with a smile” (IRB29) for
unrealistic requests for rushed approval. An administra-
tor, originally from the South, uses “Southern charm”
and a sense of humor. When PIs don’t turn in paper-
work, she says she tries to take the blame, rather than
confronting them with their negligence.
PIs will say they brought paperwork over, and I know
they didn’t. They are sure. So most of the time, if
there was an error, or they didn’t send something, I
try to be first to say, “You brought that consent form
to me the other day, and I have absolutely no idea
what I’ve done with it. Could you send me another
one, please?” It doesn’t really bother me anymore. PIs
will backdate memos to the IRB, but we have a time-
clock. I’ll say: “I know you intended to get that over
here. I’m so sorry. Can we deal with it now? How can
we help you today?” I say that because I’m not saying
that they didn’t turn it in. I’m trying to give them an
out so that they don’t have to say, “I promised that,
but have no idea what happened!” It works a lot better
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must have misplaced it. Do you have another copy?”
rather than, “Oh, we never received it.” They know
they didn’t bring it. But we say, “We have looked high
and low for that, but if you bring us another copy this
afternoon, we’ll see if we can work it into the
schedule.” It just doesn’t do any good to make
demands. Let’s just move forward and see what we
need to do to get everything running again. IRB13
Thus, IRBs can seek to defuse potential tensions be-
fore these erupt.
Educating PIs
Interviewees felt that PIs and research staff range widely
in quality and quantity of prior education concerning re-
search ethics and IRB procedures. Interviewees thought
that institutions vary in whether they require training in
the Responsible Conduct of Research (RCR) for all staff
involved in all research, and if so, how much. Several
interviewees want the federal government to mandate
comprehensive training more clearly, “requiring educa-
tion in human subjects protection for everybody”
(IRB26).
Since IRB members sensed deficits in investigators’
training in these areas, “research ethics training,” now
formally required by many institutions, may often con-
sist merely of relatively short on-line exercises. Key
aspects of issues, such as definitions of “adverse events,”
may not be included in Good Clinical Practices or Re-
sponsible Conduct of Research courses. Yet interviewees
felt that researchers may resent additional requirements.
Research conducted by trainees may pose particular
challenges. Interviewees were often unsure where and to
what degree junior PIs have learned about research eth-
ics. Interviewees thought that at some institutions, resi-
dents and other trainees were mandated to do research,
but may lack adequate methodological or research ethics
training. IRBs often felt that some trainees may have de-
ficient education in appropriate research design (e.g., as
to whether the sample size is appropriate to warrant the
study). “Residents say, ‘My faculty mentor told me what I
need for the IRB,’ and the mentor is somebody I’ve never
heard of, who’s never done research.” (IRB13)
Showing PIs the regulations
Some IRBs try to explicitly show PIs the regulations, to
demonstrate that the IRB is not arbitrary in its use of
power.
When you can tell a researcher, “The FDA says, ‘No,
you can’t do this,’ or ‘You should do this,’ or ‘have to
do this,’” they understand. If you can show them the
regs, they’re even happier. IRB25Other chairs explain to PIs not just the regulations,
but the larger underlying ethical principles as well.
There’s nothing worse than saying, “The regulation’s
required.” You always have to tie it back to an ethical
principle – say not only what they need to do, but
why. It’s not what you say, it’s the way you say it.
IRB26
Again, how IRBs communicate can thus play import-
ant roles, but can vary. Not all IRB staff may offer such
broader explanations.
Interviewees also felt that challenges existed in getting
PIs to appreciate the ethics underlying the regulations.
At times, interviewees thought that researchers resisted,
or were not interested in these explanations. The guide-
lines themselves could also shift over time.
Getting faculty or investigator buy-in, so that they
understand the reason behind the regulation, is a
challenge – being current on regulations and
institutional and regulatory expectations. IRB28
IRBs often felt that many PIs simply completed the ne-
cessary paperwork as requirements, not thinking of
these documents as concerning larger ethical principles.
They don’t think through the reasons why there’s
compliance, or put it in an ethical context. Whether
the answers are right or not may not matter to them.
IRB28
Several interviewees felt that IRB procedures and pro-
tections can themselves evolve to defend the institution
from liability more than protect the well-being of sub-
jects – thereby undermining PI dedication to these pro-
cesses as ethically important.
Optimally, there would be an ethics and integrity arm
of research, and the compliance committees’ forms
under that – bathed in ethics, rather than in
institutional protection. IRB28
Encouraging PIs to appreciate the principles under-
lying IRB concerns or requests regarding a particular
study may also require resources that IRBs may lack.
This former chair continued,
Everything would come out better if a staff person
would spend time with each investigator to improve
understanding of the ethics behind the regulation, and
help them write protocols in a more informed way.
The science would be better, the subjects would end
up better, and the investigator would feel a lot more
buy-in. IRB28
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This study, the first to explore the mechanisms through
which IRBs respond to tensions with PIs, suggests that
these committees react to conflicts with PIs in a variety of
ways – both formal and informal, involving both the form
and content of interactions and communications. These
boards differ in how and to what degree they explicitly ad-
dress conflicts with PIs – from proactively helping
researchers respond to ethical concerns, to being less
involved, and more anonymous. These data suggest that
IRBs can potentially improve relationships with PIs in sev-
eral ways, using more “open doors” rather than anonym-
ity, engaging in outreach (e.g., through clinics), enhancing
the tone as well as content of interactions, educating PIs
about the underlying ethics, and helping PIs as much and
proactively as possible. Still, these efforts can require
resources, and encounter PI resistance.
While prior studies of IRBs have tended to be quanti-
tative, and to view IRBs as static, the present data illu-
minate how these committees interact with PIs within
the context of dynamic and evolving relationships with
individuals PIs. These data thus highlight how IRBs op-
erate as part of complex social systems, and serve as
critical mediators between federal regulations and indi-
vidual researchers.
IRBs face tensions partly because PIs may in effect
“blame the messenger” (the IRB) for the news (that these
regulations need to be followed). As IRBs have certain
power [21], they can thus encounter challenges in estab-
lishing the right balance in these relationships. Since
IRBs monitor PIs, these committees’ PR efforts may be
suspect. Undoubtedly, PIs are also very busy, and con-
front many competing demands for their time, making it
difficult for them to attend meetings to which IRBs in-
vite them. Moreover, while many chairs would like PIs
educated to “understand the ethics behind the regula-
tions,” researchers may disagree with an IRB’s interpret-
ation and application of these regulations. While a
common adage is that “good ethics makes good medical
care,” some interviewees extend this notion to research
as well, feeling that good research ethics also make good
science. Yet whether this aphorism pertains to all inter-
pretations and applications of research ethics is unclear
As bureaucracies, IRBs vary not only in the formal so-
cial structures they establish, but in their tone and atti-
tudes, which can shape how communication occurs,
both formally and informally. IRBs face choices concern-
ing how, when, and to what degree to interact and com-
municate with PIs, monitoring and seeking to shape
these researchers’ attitudes and behaviours. A lack of
transparency (vs. openness) can exacerbate PI frustra-
tions with, and demonization of, IRBs. It may be easier
to demonize an “anonymous” bureaucracy, rather than
fellow human beings. IRBs, more than researchers, mayprefer the lack of transparency and argue that keeping
minutes private is easier than making this documents
more available and redacting details. But, that objection
may not sufficiently offset the potential benefits of open-
ness in fostering ethical behaviour. Redaction may be
possible. These interviewees thus raise questions of how
much anonymity is or should be permitted.
This study suggests needs for increased attention to
not only what IRBs communicate to PIs, but how (i.e.,
the tone and the nature of interactions), and to examine
the lived experiences of IRBs and PIs – the ways interac-
tions about ethics are carried out that can thus shape
the effectiveness of these interactions.
Federal regulations do not explicitly discuss these
issues, and some IRBs have developed their own
approaches that can potentially be adopted more widely.
In part, tensions may exist between IRBs and PIs be-
cause of underlying conflicting priorities – pursuing re-
search vs. protecting subjects. The strategies presented
here (e.g., “open doors”) may not wholly eliminate ten-
sions, but can help.
For several reasons, including desires to improve rela-
tionships between IRBs and PIs, the ANPRM seeks to
make formal structural changes (e.g., increasing the use of
central IRBs in multi-site studies) [6, 9, 22]. But the present
data suggest that not only the formal structure, but the
content and tone of interactions are crucial. For full board
reviews of multisite studies, for instance, centralization
alone thus may not resolve all tensions. To reduce these
strains, these data suggest that informal behaviours and
attitudes of both IRBs and PIs should also shift.
While limited resources may restrict these committees
in certain ways, other IRB approaches to enhancing rela-
tionships with PIs require relatively little time and en-
ergy (e.g., adopting an effective tone, and sending
newsletters or “tips.”). Hence, the status quo can be
improved by encouraging IRBs to try to ameliorate
strains with PIs by adopting such approaches. Specific-
ally, IRBs should realize more fully that they have a cer-
tain degree of latitude in their interactions with PIs, and
can strengthen these relationships through not only
what, but how they communicate. If an IRB lacks
resources to institute some of these practices, the chair
can potentially present these possible approaches to in-
stitutional leaders, highlighting the benefits, in hopes of
garnering additional funds.
These data thus underscore the importance of trying
to enhance IRBs and their interactions with PIs through
not only formal macro policy (e.g., altering federal regu-
lations, and establishing centralized IRBs), but more in-
formal micro levels as well – at the level of daily
interactions and lived experiences.
As a potential solution to many of these problems, the
Institute of Medicine (IOM) report of almost 10 years
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widely. Yet the current data suggest limitations in ac-
creditation: it provides standards for formal mechanisms,
but does not address many aspects of how IRB
personnel in fact fill these functions. The present data
suggest that implicit and explicit attitudes and tone need
to be addressed as well, perhaps through further, finer-
grained, and more nuanced education, and heightened
awareness of these issues. Moreover, IRBs face chal-
lenges in part because the system is not static, but fluid,
with new scientific methods and new trainees.
Future research is needed to examine more fully how
IRBs work within these dynamic relationships with
researchers – how often, when, in what ways, and to
what degrees IRBs in fact adopt the range of approaches
described here; how successful each of these strategies
are, and can be; and what factors are associated with
IRB decisions to adopt or avoid these techniques. In
part, IRB chairs may make these choices based on the
degrees to which they and/or their members are “pro-
research;” and their prior attitudes and perceptions con-
cerning relationships with PIs. Future studies can thus
probe more fully how IRBs make these decisions, and
whether and how the approaches presented here can
lower tensions, and thereby enhance PI cooperation and
compliance with regulations, improving human subject
protection.
The potential benefits of creating cultures of “compli-
ance” and of “conscience” have been described [23-25],
but whether, when, how, and to what degree IRBs actu-
ally do or can achieve such goals has received little, if
any attention. The present data suggest that IRBs face a
range of options for facilitating such aims, but do not al-
ways adopt or follow these methods.
These data also have important implications for pro-
fessional education of IRB chairs, members and staff, re-
search investigators and staff, and trainees – to enhance
their interactions as effectively as possible.
This study has several potential limitations. These
interviews explored subjects’ views now and in the past,
but not prospectively over time, to explore changes. Par-
ticipants’ statements reflect their views and attitudes,
and do not necessarily represent objective “fact” per se,
but are nonetheless valuable in and of themselves. Inter-
views also did not include PIs at each of the institutions
contacted. However, future studies can employ these
approaches. These data reflect on in-depth interviews
with IRB chairs and members, and did not include direct
observation of IRBs engaged in meetings, or of written
IRB records. Future research can observe IRBs and
examine such documents. Yet these added data may be
hard to procure since, anecdotally, IRBs have often
required researchers to obtain consent from all IRB
members, the PIs, and protocol funders.In sum, IRBs range considerably in whether, to what
degree, and when they adopt strategies that may poten-
tially reduce tensions with PIs. Federal regulations do
not mention these approaches; yet increased awareness
of the range and benefits of these strategies can poten-
tially improve IRB interactions with researchers, thus en-
hancing the dual goals of promoting socially beneficial
science, while protecting study participants.
Appendix A
A. 1. Sample questions from semi-structured interview
Note: Additional follow-up questions were asked, as ap-
propriate, with each participant.
▪ How do you define research integrity (RI)? Do you
think IRBs and PIs view or approach RI differently, and
if so, how, when, and why? Have you seen problems in
PI non-compliance with IRB regulations? If so, what
kinds of problems? How do you address these?
▪ What kinds of tensions, if any, has your IRB faced
with PIs concerning RI or other, related issues?
▪ Has your IRB ever tried to address these tensions? If
so, how, when, why, and with what success? What
barriers, if any, did you encounter? What, if anything,
has helped in addressing these tensions with PIs? How,
when, why, and with what result?
▪ Do you have any other thoughts about these issues?
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